Comparative study between cabergoline and intravenous calcium in the prevention of ovarian hyper stimulation in women with polycystic ovarian disease undergoing ICSI .

Trial Profile

Comparative study between cabergoline and intravenous calcium in the prevention of ovarian hyper stimulation in women with polycystic ovarian disease undergoing ICSI .

Recruiting
Phase of Trial: Phase III/IV

Latest Information Update: 24 Jun 2016

At a glance

  • Drugs Cabergoline (Primary) ; Calcium gluconate
  • Indications Ovarian hyperstimulation syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top